Diagnostic value of otoacoustic emissions. 1 |
| |
Authors: | N Schmuziger R Hauser R Probst |
| |
Affiliation: | PET Centre, Clarke Institute of Psychiatry, Toronto, Ontario, Canada. aaw@clarke-inst.on.ca |
| |
Abstract: | Analogues of the potent and selective 5-HT1A ligand, WAY 100635, were synthesized and examined as potential candidates for imaging 5-HT1A receptors by positron emission tomography (PET). Several of the analogues displayed nanomolar affinity for the 5-HT1A receptor, comparable to WAY 100635. Three of these were examined in a model of human liver metabolism vis-à-vis WAY 100635. All showed a markedly lower propensity for amide hydrolysis than WAY 100635. Radiolabelling of these three potential PET radiotracers with carbon-11 was readily achieved from 11C]-iodomethane, and the newly synthesized radioligands were tested in vivo in rats for binding to 5-HT1A receptors. Whereas two of the ligands failed to bind to 5-HT1A receptors in vivo, one was successful. The latter, 11C]-7 4-(2'-methoxyphenyl)-1-2'-N-(2'-pyridinyl)-2-bicyclo2.2.2]octanec arboxamido]ethyl]-piperazine], showed good brain penetration, hippocampal:cerebellar ratios of 10:1 at 45 min postinjection. Blocking studies with a variety of drugs demonstrated that the binding of 11C]-7 in vivo was selective for 5-HT1A receptors. 11C]-7 is a promising candidate as a ligand for imaging 5-HT1A receptors by PET. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|